Adam joined C4 Therapeutics in February 2019 and is the Chief Medical Officer. Prior to joining, Adam was at Novartis Institutes for Biomedical Research, most recently as Senior Director, where he led several early development programs. Before transitioning to industry, Adam was a medical oncologist at Massachusetts General Hospital researching resistance mechanisms to targeted therapies. He trained at Massachusetts General Hospital in internal medicine, and in medical oncology at the Massachusetts General Hospital Cancer Center and the Dana Farber Cancer Institute. Adam holds an M.D., as well as a Ph.D. in Neuroscience, from the University of Pennsylvania School of Medicine.